This website is intended for UK healthcare professionals only Log in | Register

Tag Archives: EUROPA

News from the 2010 Congress of the European Society of Cardiology

September 2010 Br J Cardiol 2010;17:211-14

News from the 2010 Congress of the European Society of Cardiology

Abstract

Highlights of this year’s European Society of Cardiology Congress, held in Stockholm, Sweden, from August 28th to September 1st included a new drug which benefits heart failure by slowing heart rate, and more exciting results from oral compounds that could replace warfarin in various indications. Highlights of this year’s European Society of Cardiology Congress, held in Stockholm, Sweden, from August 28th to September 1st included a new drug which benefits heart failure by slowing heart rate, and more exciting results from oral compounds that could replace warfarin in various indications. SHIFT: ivabradine shows benefit in heart failure

| Full text

May 2004 Br J Cardiol 2004;11:195-04

Management of coronary artery disease: implications of the EUROPA trial

Kim M Fox

Abstract

No content available

| Full text

January 2004 Br J Cardiol 2004;11:65-8

The ACTION, EUROPA and IONA trials: similarities, differences, outcomes and expected outcome

Johannes A Kragten, Gilbert Wagener

Abstract

No content available

| Full text

March 2002 Br J Cardiol 2002;9:158-62

The clinical application of ACE inhibitors in coronary artery disease

Abba Gomma, John Henderson, Henry Purcell, Kim Fox

Abstract

No content available

| Full text

For healthcare professionals only

Add Banner

Close

You are not logged in

You need to be a member to print this page.
Find out more about our membership benefits

Register Now Already a member? Login now
Close

You are not logged in

You need to be a member to download PDF's.
Find out more about our membership benefits

Register Now Already a member? Login now